4.83
+1.05%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About North China Pharmaceutical Co
Its shares trade on Shanghai under the ticker 600812.SS. It has been listed since 14 January 1994. In the fiscal year to 31 December 2025, it reported revenue of CN¥9.24bn and net income of CN¥183.1m. At that date it held total assets of CN¥21.39bn and shareholders' equity of CN¥5.51bn.
North China Pharmaceutical Co., Ltd. engages in the manufacture and sale of antibiotics, vitamins, and pharmaceutical products. The company is headquartered in Shijiazhuang, Hebei. The firm is mainly engaged in the research and development, production and sales of chemical raw materials, chemical preparations, biological preparations, pharmaceutical intermediates and nutraceuticals. The firm's products are covered in infective drugs, biotech drugs, cardio cerebrovascular drugs, nephropathy and immunomodulatory drugs, cancer therapeutic drugs, vitamins and nutraceuticals. In addition, The Company is also engaged in pharmaceutical logistics business. The firm distributes its products within the domestic market and to overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 14 Jan 1994
- Employees
- 10,952
- Website
- ncpc.com ↗
Leadership
Pay as last reported
- Mr. Lixin WangChairman of the Board, General Manager, since 2016CN¥373,600
- Mr. Zhiguang XiaoFinance Director, Chief Accounting Officer, Acting Secretary of the Board, Director
- Mr. Zhigang DuanDeputy General Manager
- Mr. Rongliang LiuDeputy General Manager
- Mr. Min ZhangDeputy General Manager
- Mr. Yao CaoDirectorCN¥200,400
- Mr. Rentao SongDirector
- Mr. Xiujun WangDirector
- Mr. Yalou WangDirectorCN¥215,300
- Mr. Zhenguo ChaiIndependent DirectorCN¥71,400
- Mr. Guangcheng PanIndependent DirectorCN¥71,400
- Mr. Yingzhe ShiIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 42
- Environment
- 67
- Social
- 42
- Governance
- 16
- Direct emissions (scope 1)
- 12,168 t
- Energy emissions (scope 2)
- 654,742 t
- Carbon reduction policy
- Yes
- Human rights policy
- No
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- North China Pharmaceutical Co Ltd employs 10,952 full-time employees in Shijiazhuang, Hebei.
- The company manufactures antibiotics, vitamins, and pharmaceutical products for domestic and overseas markets.
- North China Pharmaceutical Co Ltd produces chemical raw materials, biological preparations, and nutraceuticals.
Weaknesses
- The company's business is limited to pharmaceutical products without diversification into other sectors.
- North China Pharmaceutical Co Ltd has no mention of international expansion beyond current markets.
- The firm's focus on chemical-based pharmaceuticals may face regulatory challenges in some regions.
Opportunities
- North China Pharmaceutical Co Ltd can expand its pharmaceutical logistics business to new markets.
- The company can leverage its expertise in antibiotics and vitamins for global health initiatives.
- North China Pharmaceutical Co Ltd has potential to grow in the biotech drug segment within China.
Threats
- Regulatory changes in the Chinese pharmaceutical sector could impact North China Pharmaceutical Co Ltd's operations.
- Competition from other Chinese pharmaceutical firms may affect market share.
- Global health crises might disrupt supply chains for North China Pharmaceutical Co Ltd's products.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.